Saturday, May 08, 2021 9:46:29 PM
Anyone that wants this IP is going to have to pay fair market value for it. Period.
Folks. That will be well into the billions. Each. Promise. But Dont take my word for it. Regen. DD required. Who what where why how.
Was ONPH made an example of? Well they sure want to be signing our IP for advancement. They are paying hefty long term: equal to what the IP is worth.
Lets Vaccinate some Cancers folks.
Folks. That will be well into the billions. Each. Promise. But Dont take my word for it. Regen. DD required. Who what where why how.
Was ONPH made an example of? Well they sure want to be signing our IP for advancement. They are paying hefty long term: equal to what the IP is worth.
Lets Vaccinate some Cancers folks.
Sometimes its Skil, Sometimes its Luc.
I’d rather have 1 genuine team follower then 100 look-a-likes.
Appreciate Member Marks!
ALL IMHO
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
